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Summary 
T  ceil receptor-or mutant mice (TC1K-cx-/-), created by gene targeting of the TCR-~t gene in 
embryonic stem  cells,  spontaneously develop inflammatory bowel disease  (IBD)  resembling 
human ulcerative colitis.  Since gut-associated lymphoid tissue is likely to play an important role 
in the development of chronic intestinal inflammation, we examined the changes in the appen- 
dix lymphoid follicle (ALF) and Peyer's patches (PP) in these mice. We found the structure of 
the ALF to be remarkably similar to that of the PP in the small intestine; in both instances, 
lymphoid foUicles covered by surface epithelium (dome-formation) were found. The amount 
of proliferation in the lymphoid follicles of the appendix estimated by in vivo incorporation of 
5-bromo-2'deoxyuridine was more than two times that of PP in TCl:k-ot  -/- mice. ELISPOT 
assay showed an increase of IgA, IgG1, and IgG2a, but not IgM-secreting B  ceils in ALF of 
TCtL-cx  -/-  mice compared to TCR-cr +/-  control mice. Furthermore, TCR.-c~  -/- mice re- 
vealed an increase of autoantibody-producing B cells against  the cytoskeletal protein tropomy- 
osin in ALF as compared to PP. When TClq.-et  -/- mice underwent appendectomy at a young 
age (3-5 wk), the number of mesenteric lymph nodes cells at 6-7 mo were markedly less than 
in the sham-operated TCR-~x  -/- mice. Furthermore, appendectomy at 1 mo of age suppressed 
the development of IBD, with only 3.3% of these mice developing tBD in the 6-7-mo period 
of observation. In contrast, "-~  of controls, including the sham-operated TCR-cx  -/- mice, 
developed IBD during this period. These results suggest that ALF, rather than PP, is the prim- 
ing site of cells involved in the disease process and plays an important role in the development 
oflBD in TCP,-cx  -/- mice. 
G 
ut-associated  lymphoid  tissue,  consisting  of Peyer's 
patches  (PP), intraepithelial lymphocytes (IEL) 1,  and 
lamina propria lymphocytes in the small and large intestine, 
mesenteric lymph nodes  (MLN),  and  the  appendix lym- 
phoid follicle (ALF),  act as the inductive and effector sites 
of the mucosal immune system (1, 2, 3).  The structure of 
PP  is  characterized  by  the  follicle-associated  epithelium 
containing  specialized  epithelial  cells  (M  cells)  overlying 
lymphoid follicles  (4,  5).  M  cells, which transport luminal 
antigens to the mucosal immune cells, also have been iden- 
tified in the colonic epithelium over the lymphoid follicles 
in mice and in the appendix of rabbits  (5, 6). The PP are 
involved in the infection and subsequent immune response 
against  enteropathogens, including the group of microbes 
capable of selective attachment to M  cells,  such as Salmo- 
nella  typhi,  Yersinia  enterocolitica,  and reovirus  (4, 7).  M  cells 
7  Abbreviatiom used in this paper: ALF, appendix-lymphoid  follicle; BrdU, 
5-bromo-2'deoxyuridine;  ELISPOT, enzyme-linked  immunospot; IBD, 
inflammatory bowel disease; MLN, mesenteric  lymph nodes; PP, Peyer's 
patch; SFC, spot-forming  cells; UC, ulcerative  colitis. 
overlying PP  are  also  capable  of taking  up  non-invasive 
bacteria such as  Vibrio cholerae and Escherichia coli-RDEC  (4, 
8,  9).  In contrast, the  immunological function of the  ap- 
pendix has not yet been defined. 
Although  mucosal immune  mechanisms  are considered 
to be important in the development of human IBD (ulcer- 
ative colitis [UC]  and Crohn's disease),  the exact cause of 
these  disorders  has  remained  unknown  (10).  Recently,  a 
number  of experimental  models  of IBD  have  been  de- 
scribed (11-15). These models include the development of 
spontaneous  chronic  intestinal  inflammation  in  TCR-cx 
and -[3 mutant mice and mice deficient in IL-2 and IL-10 
(16-18). The IBD is more severe and present more consis- 
tently in TCR-cC/-  mice than in TCR-[~ -/-  mice (16). 
No known pathogenic organisms have been identified as a 
cause of IBD in these mice (11,  16).  In TCR-cc/-  mice, 
the T cell population is composed ofTCR-y8 T ceils and a 
unique population of T  cells bearing TCR-J3 chain on the 
ceil surface in the absence ofa TCR-ot chain (TCR-ct-[3 + 
T  cells)(19,  20). The TCR-~/B T  cells in TCR-cx  -/- mice 
increase with age (19) and after pathogenic infection (21). 
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stimulation with minor lymphocyte stimulating superanti- 
gen  1  (22).  Although B  cells can develop and differentiate 
in these  mice,  the  capacity to  regulate local T  cell and  B 
cell proliferation may be lost in the absence of TCFL-a+[3  + 
T  cells (21, 23, 24). 
Mucosal  immune  responses  are  most  likely  to  be  in- 
volved  in  the  development  of IBD  in  TCR-a -/-  mice 
(16,  25).  A  possible role  of the  appendix in the  develop- 
ment  of human  IBD  has  been  suggested  (26).  Since  im- 
mune responses to enteric bacteria have been postulated to 
pIay an  important  role in  the pathogenesis of IBD in  the 
experimental animals  (11,  12,  17,  27),  and  since appendix 
and cecum act as a reservoir of enteric bacteria, we exam- 
ined  the  role  of appendix in  the  development  of IBD  in 
TCI<-cl  -/-  mice. 
Materials and Methods 
Mice.  Colonies ofTCR-~x -/  mutant mice (19) were devel- 
oped at the Massachusetts  General Hospital from mice provided 
by Drs. P. Mombaerts and S. Tonegawa (Massachusetts Institute of 
Technology). These mice are derived genotypically from two (H- 
2  b) strains, 129/Sv and C57BL/6.  C57BL/6  were purchased from 
The Jackson Laboratory (Bar Harbor, ME). TCR-o~ heterozygous 
mice (TCR-& +/-) were generated by crossing TCR--a -/- mice 
with C57BL/6, background mice ofTCR-o~ -/- mice. The mice 
were  housed  in  specific pathogen-free facility of Massachusetts 
General Hospital. Due to the presence of Pneumocystis carinii infec- 
tion of lungs in older mice (16),  TCR-o~ -/- breeder mice were 
treated with oral administration of sulfamethoxazole and trime- 
thoprim  (Schein Pharmaceutical, Port Washington,  NY)  to  in- 
crease breeding ofTCR-oL -/- mice. This treatment did not effect 
development of IBD. 
Antibodies.  For  flow  cytometry,  CD3e  (145-2C11)-FITC 
(Boehringer  Mannheim,  Indianapolis,  IN.),  B220  (RA3-6B2), 
CD4  (lKM4-5),  CD8oe  (53-6.7),  CD813 (53-5.8),  o~E  (M290)- 
FITC, TCR-13  (H57-597),  TCR-8  (GL3),  CD23  (B3B4),  and 
CD5  (53-7.3)-PE  (PharMingen,  San  Diego,  CA)  mAbs  were 
purchased.  For immunohistochemical analysis,  biotin-anti I-A  TM 
(25-9-17; PharMingen) and purified anti-BrdU (Sera-Lab, Craw- 
ley Down, England) mAbs, and mAbs to B220,  TCR-~, TCP,.-8, 
IgM, and IgD (PharMingen) were used. 
Histological and Immunohistochemical  Analysis.  For histological ex- 
amination, specimens were obtained from five intestinal regions: 
rectum, distal and proximal colon, cecum, and appendix in every 
mouse tested. Specimens were fixed in 3% buffered formalin and 
embedded in paraffin.  Multiple 4-1xm sections were stained with 
hematoxylin and eosin. The severity of UC-like disease was de- 
termined according to the diagnostic criteria previously described 
(16). 
For immunohistochemical analysis, tissue specimens were em- 
bedded in OCT compound, snap frozen in liquid nitrogen, and 
then  subsequently  stored at  -80~  4-~m  cryo-sections were 
stained by an avidin-biotin complex method (16). 
Ceil Preparation.  PP  cells were  extracted as described previ- 
ously (28).  Grossly, ALF was found near the tip of the appendix 
and the appearance was similar to PP, forming a gray-white bulg- 
ing on the peritoneal surface (Fig. 1 A). PP and ALF were excised 
from the outside by a blade and crushed gently by 25-gauge nee- 
dles.  Cell suspensions in medium  (RPMI-1640  containing am- 
photericin B, penicillin, streptomycin, and 2% FCS) were passed 
through glass wool columns under sterile conditions. 
MLN cells were extracted according to the method previously 
described (25). After removal of fat, all grossly recognizable MLN 
were dispersed gently using 25-gauge  needles and the  resulting 
cell suspension was passed through a nylon membrane (60 lain). 
Flow Cytometry.  Between  2  X  10  s and  5  X  105  cells  were 
washed with FACS  |  buffer (PBS containing 0.2% BSA and 0.1% 
sodium azide), blocked with 50  gtl of FACS  |  buffer containing 
10%  normal rat and hamster serum  (Jackson  ImmunolKesearch 
Labs.,  Inc., West Grove, PA) at 4~  for 20 min, and incubated 
with the FITC- and PE- mAbs listed above at 4~  for 30 rain. 
After washing with FACS  |  buffer, cells were analyzed using Lysis 
II software on a FACScan  |  (Becton Dickinson, Mountain View, 
CA). In some experiments, anti-FcylI/III was used to block Fc- 
receptor. 
In Vivo BrdU Incorporation.  For labeling of proliferative cells 
in vivo, 5-bromo-2'-deoxyuridine (BrdU)(Sigma chemical Co., 
St. Louis, MO) was injected intraperitoneally (100 Ixg/g in PBS) 
1 h before killing. BrdU incorporated cells were detected by anti- 
BrdU mAb as described previously (29) using frozen and paraffin- 
embedded  sections.  Deparaffinized paraffin-embedded  sections 
were treated with 0.1% trypsin 37~  for 20 rain before staining 
for BrdU. After incubation with 3N  HC1  at room temperature 
for 15 rain to denature double-strand DNA, frozen tissue or par- 
affin-embedded sections were washed in PBS. Sections were then 
incubated with anti-BrdU mAb at an optimal dilution for 1 h fol- 
lowed by sequential incubations with biotinylated rabbit anti-rat 
Ig (Vector, Burlingame, CA) and avidin-biotinylated peroxidase 
complexes (Dako,  Santa Barbara,  CA). After development with 
3-amino-9 ethylcarbazole (AEC)(Aldrich, Milwaukee, WI), sec- 
tions were post-fixed with  2%  paraformaldehyde and mounted 
with Glycergel. Each incubation was followed by three washes in 
PBS.  Incubation with 0.3%  H202 in PBS was used to block en- 
dogenous peroxidase activity, while sequential incubations with 
avidin and biotin (Vector) were used to block endogenous biotin. 
After staining,  sections were  observed at  X400  under  micros- 
copy. The BrdU-labeling index in ALF and PP was calculated as 
positive cells/field (X400)  and  averaged.  For counting  BrdU- 
incorporated cells  of colonic epithelium, one  high  power field 
(X200) of each of these areas was counted. We counted 20 differ- 
ent fields and the average was  calculated as the total number of 
BrdU labeled cells per 1-mm length of colonic lnucosa. 
Enzyme-Linked Immunoapot (ELISPOT) Assay f~r Detection of I2 
Isotype and Autoantibody.  The ELISPOT assay was performed as 
described previously (25,  30).  A 96-well plate with a nitrocellu- 
lose  base  (Millititer HA;  Millipore  Corp.,  Bedford,  MA)  was 
coated overnight at 4~  with  100  p,1 of tropomyosin (5 Ixg/ml; 
Sigma)(31)  in 0.1 M  carbonate buffer (pH 9.6)  or with 100 ptl of 
goat anti-mouse Ig (5 ~xg/ml; Dako) in D-PBS. After the wash, 
each well was blocked with l% BSA/PBS at 37~  for at least for 
1 h. Cells (2  X  l0  s to 5  X  102 cells/well) in 100 txl of complete 
medium (RPMI-1640 containing sodium bicarbonate, nonessen- 
tial amino acids,  sodium pyruvate, L-glutamine, Hepes, penicil- 
lin, streptomycin, and 10% FCS) were added to each well and in- 
cubated at 37~  for 16 h. To block de novo synthesis oflg, cells 
in some experiments were treated with 80 ~xg/ml cycloheximide 
(Sigma) for 3 h, washed and suspended in complete medium con- 
taining 80/.tg/ml cycloheximide before being added to each well. 
After wash with 0.05%  Tween-PBS  at least five times, alkaline 
phosphatase  (AP)-anti-Ig,  -IgG2a,  or  horseradish  peroxidase 
(HRP)-anti-IgG1  (Southern Biotechnology, Birmingham,  AL), 
HRP-anti IgM or IgA (Sera-Lab) were added to each well. After 
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and developed with nitro blue tetrazolium (NBT) and 5-bromo-4 
chloro-3-indolyl phosphate  (BCIP;  Promega  Biotec,  Madison, 
WI) or AEC. After wash with tap water, all the spots in the wells 
were counted under a dissecting microscope. Results were statis- 
tically analyzed using Mann-Whitney U-test. 
Appendectomy.  TCR-o~  -/-  (3-15  weeks  of age)  mice  were 
anesthetized by inhalation of isoflurane and after a  1-cm incision 
on abdomen, the appendix was gently pulled out and ligated with 
polypropylene suture at the border between appendix and cecum, 
and resected. The border between cecum and appendix is deter- 
mined by a  slight constriction as shown  in  Fig.  1 A.  In sham- 
operated group, TCR-a -/- mice were anesthetized and under- 
went 1-cm abdominal incision without excision of the appendix. 
These mice were killed at 6-7 months of age. 
Results 
Structure of Appendix Lymphoid Follicle.  There  are  two 
major differences between  the  appendix in  mice  and  hu- 
mans.  Grossly, the appendix in mice (Fig. 1 A) is relatively 
larger with a wide lumen continuous with cecum as com- 
pared to cord-like appearance of human  appendix. Micro- 
scopically, a  single large  lymphoid follicle is  present  near 
the  tip of the mouse  appendix, whereas lymphoid follicles 
exist as clusters in the human appendix. 
Figure  1.  (A) Appendix (Ap), 
appendix  lymphoid  follicle (ar- 
row), and cecum (Ce) of a TCR- 
c~  -/-  mouse are shown. Arrow 
head  indicates the  border  be- 
tween cecum and appendix. (B) 
Histology of the  appendix-lym- 
phoid  follicle shows dome-for- 
mation (￿  (C and D) Immu- 
nohistochemical  analysis  of 
frozen  tissue sections shows in 
vivo BrdU-incorporated  cells in 
PP  (C)  and ALF (D)  of TCR- 
a -/-  mice  (20  weeks  of age). 
There  are more  stained cells in 
ALF as compared to PP. 
In mice, the structure of ALF is remarkably similar to PP 
showing a monolayer of mucosal epithelium without gob- 
let  cells,  termed  follicle-associated epithelium,  overlying 
the lymphoid follicle (Fig.  1  B). ALF also shows glandular 
follicle-formation, a  characteristic feature  of colonic  lym- 
phoid  follicle.  Immunohistochemical  analysis showed  the 
presence  of/a-positive macrophage-like cells between  the 
epithelium and lymphoid follicle in the appendix (data not 
shown), indicating the presence of antigen-presenting cells. 
Phenotypic Analysis of  ALF and PP Cells.  The  propor- 
tions of B  cells and T  cells in the PP and ALF of TCR-o~ -/- 
mice  and  TCIL-e~  +/-  mice  were  similar  (Table  1).  In 
TCR-oL -/-  mice (20 wk old), maintained under pathogen- 
free  conditions,  PP  and  ALF  were  composed  of 86.2  + 
2.1% and 85.4  +  4.2% ofB220+CD23 + cells, respectively. 
CD3 +  T  cells were  11.3  •  3.2%  and  12.4  ~  5.3%  in PP 
and ALF, respectively. The proportions of TClk-o~-  [3 + cells 
in  the  CD3 §  T  cell population in  PP  (41.4  +  5.4%)  and 
ALF (51.7  +  2.5%)  were markedly higher than in periph- 
eral lymphoid tissue  (Fig.  2).  Among  the  T  cells isolated 
from spleen and MLN in TCR-o~ -/-  mice, TCR-o~-[3 + T 
cells were less than 25% ofCD3 + T  cells. In ALF of TCR- 
ix-/-mice, 50.0  •  11.1  and 44.3  +  14.0 ofTCR-el-[3+ T 
cells  were  CD4 +  CD8{i-and  CD4-  CD8{I-  (DN),  re- 
spectively. In addition, over 80%  and  10% of TCR-o~-[B + 
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B220+CD23 +  CD3e +  TCIL-I3/CD3*  CD4/TCR.-]3* 
TCR-cr +/-  PP  80.3+6.2  19.5+-3.2  90.5--_2.4  64.0+-6.6 
ALF  81.6-+-4.2  16.2+- 1.4  92.6 +- 1.6  63.4+-3.7 
TCR-ot  -/  PP  86.2+-2.1  11.3+-3.2  41.4+5.4  44.4-4-8.4 
ALF  85.4---+2.1  12.4-+5.3  51.7+2.5  50.0-  + 11.1 
*Phenotype of PP and ALF lymphocytes in TCR-a  -/- mice and TCR-a  +/- mice was determined by flow cytometric analysis. All mice were 
maintained under pathogen free conditions. The age of mice was between 20 and 26 wk. 
*  Percentages of TCRq3  + cells witin CD3e + ceils and CD4 + cells  within TCR-[~  + cells. 
~Data averaged from 7 TCR-oe  +/- and 18 TCP,.-~x  -/- mice represent mean+SEM. 
T  cells expressed CD5  and M290,  respectively, indicating 
that most of TCR-&-[3  +  T  ceils were thymic dependent. 
lmnmnohistochemical  analysis of MLN, ALF and PP using 
anti-CD3, TCR.-8, IgM, IgD, and B220 confirmed the re- 
suits obtained with FACScan  |  analysis (data not shown). 
Increase of Proliferative Cells in ALF.  To  compare  the 
frequency of proliferative lymphoid cells in PP and ALF in 
TCR.-Ix  -/-  and TC1L-a  +/-  mice, in vivo BrdU incorpo- 
ration  in  lymphoid  cells  was  analyzed.  The  results  are 
shown in Figs. 1,  C  and D  and 3. In TCR-0~  -/- mice, the 
number of BrdU-incorporated cells was more than twofold 
higher in ALF than in PP; the labeling index was 59.9  --- 
4.7 and 25.4 +-- 2.1  cells/field in ALF and PP, respectively 
(P <0.005).  Furthermore, in ALF, the BrdU-incorporated 
cells increased about threefold in TCl:k-o~ -/- mice as com- 
pared to TCR-cl  +/- mice (Fig. 3). However, in PP, there 
was  no  difference  in  the  number of BrdU-incorporated 
cells between TCR-oc/-  and TCtL-&  +/-  mice  (Fig.  3). 
The proliferative cells were found not only in B  cell areas 
(follicles),  but  also  in  the  interfollicular areas  in  ALF  of 
TCR-oe  -/- mice. This finding suggests that both B  and T 
ceils proliferate. 
Activation  of  and  Autoantibody  Production  by  B  cells  in 
ALF.  In TCR-0~  +/-  mice,  the  number of IgA-,  IgGl-, 
and IgG2a-producing B cells in PP was higher than in ALF 
(Fig. 4 A), indicating that, in normal mice, PP seems to be 
more reactive to foreign antigens than ALF. However, in 
TCR-c~  -/-  mice,  the  numbers of IgA-,  IgGl-,  IgG2a-, 
and  IgM-secreting B  ceils  in ALF  were  similar or  more 
than that in PP (Fig. 4 A). These findings indicate that acti- 
vation and Ig-switching of B  cells in ALF of TCR-c~  -/- 
m Qa 
"-"  Figure 2.  Frequency  of TCR-  ~  60' 
"~  513  13  + cells  in the CD3+ T cell  pop- 
~,  ulation of ALF, PP,  MLN, and 
"~  spleen from 20 TCR-o~  -/- mice  ~  40' 
e~  (20  wk  old). Cells were incu- 
25  bated  with  FITC-anti-CD3~ 
+r  (145-2C11), and PE-anti-TCR-B  ~  2d 
r  (GL3), or PE-anti-TCR-[3  (H57- 
["  0  597) mAbs  and then subjected to 
SP  MLN  pP  ALF  two color  flow cytometric  analysis,  m 
mice is more  than that present in TCR-cx +/-  mice.  Pre- 
treatment of these cells with 80 Ixg/ml of cycloheximide, a 
protein synthesis inhibitor, reduced Ig producing spots  to 
5-10% of their level, indicating that the spots were a result 
of de novo protein synthesis. 
Antibodies to the cytoskeletal protein tropomyosin have 
been reported to be present in patients with UC  (31).  We 
have recently found that TCR-cx  -/-  mice with IBD  also 
produce autoantibodies to tropomyosin (25). The develop- 
ment of antibodies to tropomyosin may be due to molecu- 
lar mimicry by viral or bacterial antigens for tropomyosin 
(32, 33). In the present study, we investigated the presence 
of  B  cells  secreting  autoantibodies  to  tropomyosin  by 
ELISPOT assay.  ELISPOT assay showed over twofold in- 
crease in B  cells secreting autoantibodies to tropomyosin in 
ALF as compared to PP of TCR-ot  -/- mice. Furthermore, 
the number of anti-tropomyosin secreting B cells was more 
in ALF  of TCR-ot  -/-  mice  as  compared  to  TCR-ct § 
mice (Fig. 4/3). 
Effect of Appendectomy.  To  investigate  the  role  of ap- 
pendix in the development of IBD, we performed appen- 
dectomy in 49 TCIK-o~  -/-  mice at different ages.  The lit- 
termates  which  underwent sham-operation were  used  as 
controls. 12 (80%)  out of 15 control TCR-cx  -/- mice (6-7 
months  of  age)  revealed  gross  and  microscopic  features 
characteristic  of IBD  in TCIK-o~  -/-  mice.  These findings 
are consistent with our previous report that 83% of TCIK- 
e~ -/-  mice at 24-30 weeks of age develop IBD spontane- 
Figure 3.  In vivo BrdU-incor- 
porated cells in the ALF and PP 
of TCR-a  -/-  and  TCR-c~  +'- 
mice. The numbers indicate av- 
erages  of  BrdU-incorporated 
cells/field (￿  from groups of 
7 mice (2{) wk old). Open bars 
represent TCR-a  +/-  and  solid 
bars indicate TCR-~x  -/-  mice. 
There are significantly  more (P 
<0.005) proliferative cells in the 
ALF of TCR-Ix  -/  nfice  as com- 
pared to that in PP ofTCP--~x  -j 
mice or PP and ALF of TCR- 
li~ +/  nlice. 
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Figure  4.  Quantification of Ig and autoantibody-secreting cells in ALF 
and PP of age-matched (20--24  wk) TCR-o~  -/- and TCR-cO/- mice by 
ELISPOT assay. (A) The frequency oflgM, IgA, IgG1, and IgG2a secret- 
ously (16,  25).  The disease  involved the  entire colon in- 
cluding cecum and  appendix,  and was  characterized by a 
thickened colonic wall with marked elongation of crypts, 
depletion of goblet cells, occasional crypt abscesses and the 
presence of mixed inflammatory cell infiltrate in the lamina 
propria (Fig.  5)(16). In contrast, only one (3.3%) out of 30 
TCR-ot  -/-  mice,  appendectomized at  3-5 weeks  of age, 
showed  the  findings  of IBD  (Fig.  6).  However, the  fre- 
quency of IBD development in the appendectomized mice 
increased  depending  on  the  period when  appendectomy 
was performed; histological evidence of IBD was detected 
in 4  (33%) out of 12 TCR-oL  -/- mice and 6  (75%) out of 
ing B  cells in PP and ALF are shown. (/3) The numbers of B  cells secret- 
ing autoantibody (Ig) against tropomyosin are shown. Open bars indicate 
TCR-~x  +/- and solid bars indicate TCR-c~  -/- mice. The values are mean 
of spot-forming cells  (SFC)  +  SEM from 18  TCR-ot +/-  and 24 TCR- 
a -/- mice. Significant differences between the values for TCR-~x  -/- and 
TCR-a +/- mice are indicated: *P <0.05, **P <0.005￿9 
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Figure  5.  Histological findings and pro- 
liferative epithelial  cells in  the rectum of 
TCR-oL  -/- mice after sham-operation (A 
and  C)  or  appendectomy at  3  weeks  of 
age  (B  and  D).  These mice  were  main- 
tained in the same cage under pathogen- 
free conditions and killed  at 7  months of 
age. A  and B show histological examina- 
tion from the rectum.  C  and D  show in 
vivo BrdU-incorporated epithelial cells in 
the rectum as revealed by immunoperoxi- 
dase  staining  of  paraffin-embedded  sec- 
tions.  The  rectum of the  sham-operated 
mouse shows histological features of IBD 
(A)  and many more stained crypt epithe- 
lial  cells  (C)  as  compared  to  the  normal 
histological features (B) and normal num- 
bers of stained crypt epithelial cells (D) in 
the appendectomized mouse. Severe 
Mode. 
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~.  Mild 
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Figure 6.  Effect of appendectomy  on the development oflBD. Groups 
of TCR-ct  -/- mice were sham-operated  or appendectomized  at different 
ages (3-5 wk, 6-12 wk, and over 12 wk), and were killed at 6-7 months 
of age. The severity of IBD (no, mild, moderate,  and severe disease) was 
determined  by histological examination as previously described (16). 
12  TCR-cx -/-  mice  which  underwent  appendecton W  at 
6-12  weeks  of age and  over 12  weeks  of age,  respectively 
(Fig.  6).  Analysis  of the proliferative index  of colonic  epi- 
thelial cells by in vivo incorporation  of BrdU can be a use- 
ful method for the detection of colonic epithelial prolifera- 
tion,  a  feature  of IBD  (34).  Therefore,  we  also  examined 
the  proliferative  index  of epithelium  in  the  rectum  and 
proximal  colon  of the  TCR-et -/-  mice  with  appendec- 
tomy  or  sham-operation  and  the  TCR-cx +/-  mice.  The 
proliferative  index  of  colonic  epithelium  in  TCR-a  -/- 
mice  appendectomized  at  3-5  wk  was  similar  to  that  of 
TCR-c~ +/-  mice (Figs.  5  and 7).  In contrast,  there was in- 
creased  colonic  epithelial  proliferation  in  sham-operated 
mice and in the mice which  underwent  appendectomy  af- 
ter  6  weeks  of age.  These  results  support  the  histological 
findings  of absence  of 1BD in the appendectomized  TCR- 
oL -/-  mice. 
Decrease  of MLN  Cells  in  Appendectomized  TCR-cC l- 
Mice.  Both B  and T  lymphocytes, primed by gut-lumenal 
antigenic  stimulation,  migrate  first  into  MLN,  enter  the 
systemic circulation via the thoracic  duct,  and  then  prefer- 
entially recirculate back to intestinal mucosa (35,  36).  Since 
the  increase  of MLN  cells  relates  to  the  development  of 
IBD  in  TCR-cx -/-  mice  (16,  25),  we  examined  the 
changes  of cell  number  in  MLN.  The  total  numbers  of 
MLN  cells in TCR-eL -/-  mice,  which  underwent  appen- 
dectomy  at  young  age  (3-5  wk),  were  significantly  less 
(2770  --+  322  ￿  10%  P  <0.001)  than  those  of sham-oper- 
ated TCR-c~ -/-  mice (6191  __+  649  X  104).  The number of 
MLN  cells from TCR-a -/-  mice, appendectomized  at an 
older  age  (over  6  wk),  showed  no  significant  difference 
(5027  --+  468  ￿  104)  as  compared  to  the  sham-operated 
TCR-o~ -/-  mice (Fig. 8). 
Flow  cytometric  analysis  showed  that  there  was  no  dif- 
ference  in  the  proportion  of B  cells  and  T  cells  of MLN 
cells  between  the  appendectomized  TCR-(x -/-  mice  and 
the  sham-operated  TCR-eC/-  mice; MLN  of the  appen- 
dectomized TCR-~x -/-  mice consisted  of 79.5  _-  1.8%  of 
B  cells  (CD3-B220 +)  and  16.4  --  1.2%  of CD3 +  T  cells, 
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Figure 7.  Effect of appendectomy  on proliferation  of epithelial cells in 
rectum and proximal colon ofTCR-~ -/- nfice was assessed by detection 
of in  vivo BrdU-incorporated  epithelial  crypt  cells. TCR-~ -/-  mice 
were sham-operated  (at 3-5 weeks of age) or appendectomized  at differ- 
ent ages (3-5 wk and over 6 wk), and were killed at 6-7 months  of age. 
TCR-cO/- mice were used as normal  control.  Dots indicate the average 
(BrdU-labeling cells/1 mm ofmucosa) from 20 different fields in an indi- 
vidual mouse. The average from each group of mice is indicated as a bar. 
There is significant difference (P <0.005)  between the values for mice ap- 
pendectomized  at young age  (3-5  wk)  and  sham-operated  TCR-~-:- 
mice. 
and the percentage of B  cells and T  cells in the sham-oper- 
ated TCR-o:/-  mice was 80.7  -  1.7%  and  17.7  ___  1.7%, 
respectively. 
Discussion 
Although  the  lymphoid tissue  of the  appendix forms a 
part of the mucosal associated lymphoid system, the func- 
tion of appendix is not known. We found the structure of 
ALF to be similar to that of PP in the mouse and suggest 
that ALF, like PP, participates in the recognition of lume- 
lO 
.p 
....  - 
;  g 
3-5  6-12  3-$ wk 
Appendectomy  Sham  TCR-c~ +/" 
TCR.c~ "/" 
Figure  8.  Decrease  of MLN  cells in  TCR-c~-:-  mice appendecto- 
mized at young age (3-5 wk).  TCR-c~ -/- mice after sham-operation  or 
appendectomy  at different ages (3-5 wk and over 6 wk) were maintained 
under pathogen-free  conditions  and killed at 6-7 months  of age. TCR- 
~+:- mice (6--7 months  of age) were used as normal controls. Dots indi- 
cate  the number of total  MLN cells. The average from each  group  of 
mice tested is indicated as a bar. There is significant difference (P <0.001) 
between the TCR-& -/- mice appendectomized  at young age (3-5 wk) 
and sham-operated  mice. 
712  Role of Appendix in TCR-~ Mutant Mice nal antigens. In contrast to small intestine, where the lume- 
nal contents are continuously pushed forward, the contents 
in the appendix are retained over a period of time and pro- 
vide  a  place  for  colonization  and  proliferation  of enteric 
bacterial flora.  Although  PP has been reported  to play an 
important role for defense against lumenal pathogens, such 
as Salmonella  typhi,  Yersinia enterocolitica, reovirus,  Vibrio chol- 
erae, and E. coli-RDEC (4, 7,  8,  9),  the role of ALF in de- 
fense against these  or other pathogens is not known.  It is 
possible that PP may be involved in the recognition of for- 
eign  lumenal  antigens  (dietary  and  enteric  pathogens), 
whereas ALF  may recognize  the  normal  enteric  bacterial 
flora, which reside mainly in the cecum and appendix. 
The studies so far have not identified any pathogenic or- 
ganisms as the cause oflBD in TCR.-ix  -/- mice (16).  Sim- 
ilarly,  pathogenic  organisms  have  not  been  identified  in 
other models oflBD (11,  12).  Interestingly, the IBD in IL- 
2-deficient  mice  and  HLA-B27  transgenic  rats  does  not 
occur when the animals are maintained in a germ free envi- 
ronment (17, 27). These findings strongly suggest that non- 
pathogenic enteric bacterial flora play an important role in 
the development oflBD (12,  17, 27). Since the cecum and 
appendix are usually a reservoir of enteric bacterial flora, it 
is possible that the ALF may be involved in the generation 
of the immune response to enteric bacterial flora. In TCR- 
cx  -/-  mice,  the  proliferative  response  of ALF  cells  to  li- 
popolysaccharide  obtained  from  E.  coli serotype  026:B6 
(37) is greater than that of PP cells (our unpublished obser- 
vations). Thus, ALF may also be important in the develop- 
ment  of autoantibodies  through  molecular  mimicry.  In 
TCR-ix -/-  mice,  the  predominant  T  cells  population  is 
TCR-~/8 +  cells  (more  than  70%)  in  peripheral  blood, 
spleen and MLN (16,  20,  21).  However, the predominant 
T  cells  population  in  ALF  of TCR-ix -/-  mice is  TCR- 
ix-J3 + cells (51.7  +  2.5%), which express CD5 (a marker of 
thymus-dependence).  This  predominance  of TCR-a-J3 + 
in ALF may reflect changes due to recognition of lumenal 
antigens. We have found that the humoral response to aer- 
obic  cecal  bacteria  (E.  coh) antigens  changes  from poly- 
clonal to oligoclonal with age and development of IBD in 
TCR-ix -/- mice (38). The polyclonal response seems to be 
preserved at 7  months  of age in TCR-ix -/- mice appen- 
dectomized at 5 wk (our unpublished results).  It is possible 
that CD4 + TCR-ix-[3 + cells may be involved in this alter- 
ation of humoral response, and in the development of IBD 
in  TCR-et -/-  mice.  Recently,  thymus-dependent  CD4 + 
T  cells have been reported to be important in the develop- 
ment of IBD in mice transgenic for the human CD3~ gene 
(39). 
B cells in the human appendix express the IL-6 receptor, 
indicating that the appendix is a site for B  cell-differentia- 
tion (40).  In the current studies, we have found an increase 
of IgA-,  IgGl-,  and  IgG2a-secreting  B  cells  in  ALF  of 
TCR-0t -/- mice compared to TCR-IX  +/- (controls), indi- 
cating that activation of B cells in ALF occurs selectively in 
the  TCR-ot -/-  mice.  Furthermore,  anti-tropomyosin se- 
creting B cells were found to be increased in ALF of TCR- 
ix -/- mice. Taken together, these findings support the im- 
portance  of the  appendix as a site for the  activation of B 
cells  and the  generation  of immune responses to bacterial 
antigens in TCR-ot -/- mice. The development of IBD in 
TCR-IX  -/- mice might reflect loss of oral tolerance to mi- 
crobial  antigens  as  a  result  of the  lack  of TCP,-ix+J3 +  T 
cell-mediated suppression  of B  cells;  this  could lead to an 
autoimmune attack against the colonic epithelium, possibly 
due to cross-reactive antibodies (16).  It is also possible that 
lack of regulatory T  cells and cytokines allows development 
of inflammatory  responses  to  enteric  microbial  antigens 
(11,  12). 
Recently, it has been postulated that appendectomy may 
protect development of UC in humans (26).  In the present 
study,  we found  that  appendectomy at a young age  (3-5 
wk), but not at older age (>6 wk) suppressed the develop- 
ment oflBD in TC1k-ix  -/- mice. In addition to histological 
examination, the absence of disease in appendectomized mice 
was also  confirmed by the lack of increase in colonic epi- 
thelial proliferation as  compared to  sham-operated TCR- 
ot -/- mice. In mice appendectomized at 3-5 weeks of age, 
only  1  out  of 30  (3.3%)  developed  IBD.  Since  the  fre- 
quency of IBD was greater in TCR-ix -/- mice appendec- 
tomized after 5 weeks of age, it is possible that the cells in- 
volved  in  the  development  of  IBD  expand  beyond 
appendix and populate MLN and other mucosal lymphoid 
tissues  after 5 weeks of age. Colonic lymphoid follicles are 
more frequently detected  in  the  appendectomized TCR- 
ix-/-  mice  compared  to  controls  (unpublished  observa- 
tions).  Therefore,  it is likely that  after appendectomy the 
other lymphoid follicles  in  gut,  such as  colonic lymphoid 
follicles,  can  perform the  function  of ALF.  A  study  of a 
much larger number of animals over a long period of time 
will help determine whether appendectomy at a young age 
(3 wk) completely prevents or only delays development of 
IBD in TCR-ix -/- mice. 
Appendectomy  at  young  age  (3-5  wk)  was  associated 
with  lower  numbers  of MLN  cells  as  compared  to  the 
sham-operated  TC1k-ot -/-  mice.  We  have  previously 
found that the increase of MLN cells was related to devel- 
opment of lBD in TCR-et -/- mice (16,  25).  The number 
of MLN  cells  in  TClk-ix  -/-  mice  appendectomized  at 
young age was similar to those of age-matched TCIt.-ix  -/- 
mice without IBD, as described previously (25).  Since the 
cells primed in the gut migrate to MLN (35,  36), our find- 
ings  support the  possibility that appendix is  an important 
site for priming of the cells involved in the development of 
IBD in TC1K-ot  -/- mice. 
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